Viracta Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 76-100 of 199 matching filings.

Per page
25
Current page
4
8-K File 000-51531

8-K LICENSE AGREEMENT

Filing date
17 Dec 2019
Reporting date
13 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K LICENSE AGREEMENTS

Filing date
06 Dec 2019
Reporting date
06 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

Q3 2019 EARNINGS PRESS RELEASE 8-K

Filing date
12 Nov 2019
Reporting date
12 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
19 Sep 2019
Reporting date
17 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

Q2 2019 EARNINGS 8-K

Filing date
07 Aug 2019
Reporting date
07 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
12 Jul 2019
Reporting date
10 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
10 Jul 2019
Reporting date
10 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K NOTICE OF FAILURE TO SATISFY A CONTINUED LISTING RULE

Filing date
09 Jul 2019
Reporting date
09 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K 2019 ANNUAL MEETING VOTE SUBMISSION

Filing date
06 Jun 2019
Reporting date
06 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

Q1 2019 EARNINGS 8-K

Filing date
08 May 2019
Reporting date
08 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K DEBT REFINANCING

Filing date
29 Apr 2019
Reporting date
26 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

Q4'18 EARNINGS 8-K

Filing date
07 Mar 2019
Reporting date
07 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K 2019 BONUS PROGRAM

Filing date
04 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
22 Jan 2019
Reporting date
17 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K NOTICE OF FAILURE TO SATISFY A CONTINUED LISTING RULE

Filing date
11 Jan 2019
Reporting date
11 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K PHARMACEUTICALS UPDATE JANUARY 2019

Filing date
07 Jan 2019
Reporting date
07 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K DECEMBER 2018 ASH PRESENTATION

Filing date
03 Dec 2018
Reporting date
02 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

Q3 2018 EARNINGS PRESS RELEASE 8-K

Filing date
05 Nov 2018
Reporting date
05 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

Q2'18 8-K

Filing date
07 Aug 2018
Reporting date
07 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
26 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
25 Jun 2018
Reporting date
25 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K ANNUAL MEETING VOTE SUBMISSION

Filing date
07 Jun 2018
Reporting date
06 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
08 May 2018
Reporting date
08 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
08 Mar 2018
Reporting date
08 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K WOLFF APPOINTMENT

Filing date
07 Feb 2018
Reporting date
02 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .